MW ADVISORY, LLC’s Dr. Reddy's Laboratories RDY Stock Holding History

MW ADVISORY, LLC’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$268K	Buy	+18,505	New	+$250K	0.11%	114

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

AIM

ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return

MW ADVISORY, LLC's RDY Position: Q2 2026 in Review

MW ADVISORY, LLC opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 18,505 shares worth $268K. The stake represents 0.11% of the portfolio and ranks #114 among its holdings.

101 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

MW ADVISORY, LLC held 18,505 shares of Dr. Reddy's Laboratories worth $268K as of Q2 2026.
Dr. Reddy's Laboratories was a new MW ADVISORY, LLC position in Q2 2026.
Dr. Reddy's Laboratories made up 0.11% of MW ADVISORY, LLC's portfolio in Q2 2026, its #114 holding.
101 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on MW ADVISORY, LLC's 13F filing for Q2 2026, filed 7 Aug 2026.